(Q53995614)

23 May 2018

title

Sensitivity of Pseudomonas aeruginosa to antibiotics: emergence of strains highly resistant to carbenicillin. (English)

1 reference

23 May 2018

main subject

Pseudomonas aeruginosa

0 references

author name string

E J Lowbury

1

1 reference

23 May 2018

H A Lilly

2

1 reference

23 May 2018

A Kidson

3

1 reference

23 May 2018

G A Ayliffe

4

1 reference

23 May 2018

R J Jones

5

1 reference

23 May 2018

language of work or name

English

0 references

publication date

1 August 1969

1 reference

23 May 2018

published in

The Lancet

1 reference

23 May 2018

volume

2

1 reference

23 May 2018

issue

7618

1 reference

23 May 2018

page(s)

448-452

1 reference

23 May 2018

Changes in incidence and aetiology of bacteraemia arising in hospital practice.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2869%2990163-9

7 January 2021

Carbenicillin: a new semisynthetic penicillin active against Pseudomonas pyocyanea.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2869%2990163-9

7 January 2021

LABORATORY AND CLINICAL STUDIES OF GENTAMICIN, A NEW BROAD-SPECTRUM ANTIBIOTIC.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2869%2990163-9

7 January 2021

Clinical and laboratory studies with carbenicillin. A new penicillin active against Pseudomonas pyocyanea

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2869%2990163-9

7 January 2021

Prophylaxis and therapy for Pseudomonas aeruginosa infection with carbenicillin and with gentamicin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2869%2990163-9

7 January 2021

Resistance of Pseudomonas aeruginosa to carbenicillin.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2869%2990163-9

7 January 2021

Resistance of Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2869%2990163-9

7 January 2021

Carbenicillin Resistance in Pseudomonas aeruginosa from Clinical Material

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2869%2990163-9

7 January 2021

Use of an improved cetrimide agar medium and other culture methods for Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2869%2990163-9

7 January 2021

Bacteriological control of aureomycin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2869%2990163-9

7 January 2021

Elimination of Transmissible Drug-resistance by Treatment with Acriflavin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2869%2990163-9

7 January 2021

Fucidin for staphylococcal infection of burns

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2869%2990163-9

7 January 2021

Clinical problems of drug-resistant pathogens

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2869%2990163-9

7 January 2021

Transduction of resistance to some macrolide antibiotics in Staphylococcus aureus.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2869%2990163-9

7 January 2021

Pseudomonas infection treated with carbenicillin and gentamicin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2869%2990163-9

7 January 2021

10.1016/S0140-6736(69)90163-9

Identifiers

DOI

1 reference

23 May 2018

1 reference

23 May 2018